Rong En Tay

Title: Innovations of Rong En Tay in Epigenetic Research

Introduction

Rong En Tay is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of epigenetics, particularly in enhancing T cell effector functions. His work is crucial for advancing cancer therapies and improving immune responses.

Latest Patents

Rong En Tay holds a patent for "Compositions and methods using an epigenetic inhibitor." This patent describes novel methods for increasing T cell effector function in T cell populations. The methods involve contacting T cells with a pharmaceutical composition that includes an antagonist of histone deacetylase 3 (HDAC3). Additionally, the patent outlines methods for identifying compounds that modulate HDAC3 activity in cytotoxic T cells. He has 1 patent to his name.

Career Highlights

Rong En Tay is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts research aimed at improving cancer treatment through innovative approaches. His work has garnered attention for its potential to enhance the efficacy of immunotherapies.

Collaborations

Rong En Tay collaborates with notable researchers in his field, including Kai W Wucherpfennig. Their joint efforts contribute to the advancement of knowledge in cancer immunology and epigenetic regulation.

Conclusion

Rong En Tay's innovative research and patent contributions are paving the way for new therapeutic strategies in cancer treatment. His work exemplifies the importance of epigenetic research in enhancing immune responses.